Mindful Eating CCSN Final.pptx
•Download as PPTX, PDF•
0 likes•124 views
About this webinar: Trying to stay in the moment and slowing down can be supportive in many aspects of our lives, including fostering a positive relationship with food. Join us to explore the benefits of mindful eating, the process of being present while preparing and enjoying our food. We will look at practical tips to include mindful eating practices in our lives such as noticing hunger and fullness cues and noticing sensory aspects of mealtimes. During this workshop we will practice a mindful eating exercise together, please come prepared with one of the following foods: a raisin, a square of chocolate, a nut, or a warm cup of tea. About the presenter: Shannon Smith, BSc. RD, graduated with honours from UBC’s Food Nutrition and Health program and completed her dietetic internship with Vancouver Coastal Health in 2012. She is registered with the BC College of Dietitians and is a member of Dietitians of Canada. Shannon began her career as a dietitian in the natural grocery setting where she gained a deep understanding of food — from farms to processing, packaging, and labelling. From the grocery setting to medical clinics, she loves translating the science of nutrition to real-world food and cooking. Shannon is delighted to join the InspireHealth team where she looks forward to sharing her passion for balanced nutrition. She is especially excited to lead cooking classes that highlight the joy of exploring fresh, simple ingredients.
Report
Share
Report
Share
Recommended
CCSN Powerpoint Template Empowering Through Education.pptx
About the Webinar: Michelle Colero, Executive Director of Bladder Cancer Canada, will cover the essentials of bladder cancer facts and symptoms while also outlining the support and educational resources provided by Bladder Cancer Canada for those dealing with a diagnosis. Additionally, she’ll share ways individuals can contribute to raising awareness and supporting our community.
The Link Between alcohol-and-cancer_ccsn_2024-04-25.pptx
About the Webinar: Alcohol is classified as a Group one carcinogen and is estimated to be one of the top three causes of cancer deaths worldwide. Yet, over 40 per cent of people in Canada remain unaware that alcohol consumption increases the risk of developing at least nine cancers. In this presentation, we’ll look at what is and isn’t known about the relationship between alcohol and cancer. We’ll explore what the Canadian Cancer Society is doing to raise awareness of alcohol as a modifiable cancer risk factor, its commitment to funding world-leading research on this subject, and its advocacy for stronger policies that reduce, and increase awareness about the risk of cancer related to, alcohol consumption. Attendees will be invited to seek more information and/or take action on this important topic. We hope you’ll join us in learning more about cancer risk and alcohol — the most commonly used psychoactive substance in Canada.
2024 4 Emotional Intelligence for CCSN.pptx
Dr. Rob Rutledge returns for his first webinar of 2024 to discuss the basics behind emotional intelligence. Learn how to develop greater emotional awareness, and learn how to settle fear and frustration. Dr. Rutledge will also share tips on how to live in a more peaceful and connected way as you navigate through your cancer journey.
Challenges and Potential Solutions for Improving Health Technology Assessment...
Challenges and Potential Solutions for Improving Health Technology Assessment...Canadian Cancer Survivor Network
About the Webinar: Health technology assessment (HTA), the approval process for drugs and healthcare technology, the processes and organizations that support them, such as Canadian Agency for Drugs and Technologies in Health (CADTH), have evolved over the years in response to changing healthcare system priorities and the need to establish their legitimacy. Don Husereau will provide an overview of current processes in Canada, and highlight their perceived (and real) shortcomings and what can be done to overcome these. He will highlight that some perceived weaknesses (such as review times) are not as bad as they appear while perceived strengths (such as stakeholder involvement) need considerable improvement. He will also discuss other opportunities for HTA to innovate and whether there are current plans to address these.CBoC_IMC_Time to Patient Presentation_CCSN.pdf
About this Webinar: The time between regulatory approval for new drugs and when drugs became publicly available to patients averaged 736 days (25 months) in 2022. This is double the average time reported in comparable Organisation for Economic Development (OECD) countries. This webinar will highlight variations in drug listing time for new drugs across time, provinces, and type of drugs (oncology vs. non-oncology). It will also present the specific phases involved in moving a drug from approval stage to listing, and the time spent in each. This Conference Board of Canada analysis uses IQVIA’s Market Access Metrics Database (2012 to 2023), which tracks all new products and their indications through the Canadian access journey.
Pancreatic Cancer an Overview - CCSN 2024-02-29
About the Webinar: Learn about pancreatic cancer symptoms, diagnosis, treatment options, statistics, supports and barriers. The presentation will also include some helpful tools that can improve quality of life for those with pancreatic cancer, including the Craig's Cause's PERT (Pancreatic Enzyme Replacement Therapy) calculator and available patient support programs.
Bulk Importation MSSC Presentation 2024-02-final .pdf
As referenced by John Adams in his 2024 CCSN Webinar on the US importing drugs from Canada, this is a slide deck from Health Canada which outlines the timetable and actions taken by the government on this particular issue.
CCSN Presentation John Adams February 1 2024 2.pptx
About this Webinar: John Adams takes a dive behind the headlines, news stories and media releases to better understand any real threats to Canadian patients getting the prescription drugs they need.
Recommended
CCSN Powerpoint Template Empowering Through Education.pptx
About the Webinar: Michelle Colero, Executive Director of Bladder Cancer Canada, will cover the essentials of bladder cancer facts and symptoms while also outlining the support and educational resources provided by Bladder Cancer Canada for those dealing with a diagnosis. Additionally, she’ll share ways individuals can contribute to raising awareness and supporting our community.
The Link Between alcohol-and-cancer_ccsn_2024-04-25.pptx
About the Webinar: Alcohol is classified as a Group one carcinogen and is estimated to be one of the top three causes of cancer deaths worldwide. Yet, over 40 per cent of people in Canada remain unaware that alcohol consumption increases the risk of developing at least nine cancers. In this presentation, we’ll look at what is and isn’t known about the relationship between alcohol and cancer. We’ll explore what the Canadian Cancer Society is doing to raise awareness of alcohol as a modifiable cancer risk factor, its commitment to funding world-leading research on this subject, and its advocacy for stronger policies that reduce, and increase awareness about the risk of cancer related to, alcohol consumption. Attendees will be invited to seek more information and/or take action on this important topic. We hope you’ll join us in learning more about cancer risk and alcohol — the most commonly used psychoactive substance in Canada.
2024 4 Emotional Intelligence for CCSN.pptx
Dr. Rob Rutledge returns for his first webinar of 2024 to discuss the basics behind emotional intelligence. Learn how to develop greater emotional awareness, and learn how to settle fear and frustration. Dr. Rutledge will also share tips on how to live in a more peaceful and connected way as you navigate through your cancer journey.
Challenges and Potential Solutions for Improving Health Technology Assessment...
Challenges and Potential Solutions for Improving Health Technology Assessment...Canadian Cancer Survivor Network
About the Webinar: Health technology assessment (HTA), the approval process for drugs and healthcare technology, the processes and organizations that support them, such as Canadian Agency for Drugs and Technologies in Health (CADTH), have evolved over the years in response to changing healthcare system priorities and the need to establish their legitimacy. Don Husereau will provide an overview of current processes in Canada, and highlight their perceived (and real) shortcomings and what can be done to overcome these. He will highlight that some perceived weaknesses (such as review times) are not as bad as they appear while perceived strengths (such as stakeholder involvement) need considerable improvement. He will also discuss other opportunities for HTA to innovate and whether there are current plans to address these.CBoC_IMC_Time to Patient Presentation_CCSN.pdf
About this Webinar: The time between regulatory approval for new drugs and when drugs became publicly available to patients averaged 736 days (25 months) in 2022. This is double the average time reported in comparable Organisation for Economic Development (OECD) countries. This webinar will highlight variations in drug listing time for new drugs across time, provinces, and type of drugs (oncology vs. non-oncology). It will also present the specific phases involved in moving a drug from approval stage to listing, and the time spent in each. This Conference Board of Canada analysis uses IQVIA’s Market Access Metrics Database (2012 to 2023), which tracks all new products and their indications through the Canadian access journey.
Pancreatic Cancer an Overview - CCSN 2024-02-29
About the Webinar: Learn about pancreatic cancer symptoms, diagnosis, treatment options, statistics, supports and barriers. The presentation will also include some helpful tools that can improve quality of life for those with pancreatic cancer, including the Craig's Cause's PERT (Pancreatic Enzyme Replacement Therapy) calculator and available patient support programs.
Bulk Importation MSSC Presentation 2024-02-final .pdf
As referenced by John Adams in his 2024 CCSN Webinar on the US importing drugs from Canada, this is a slide deck from Health Canada which outlines the timetable and actions taken by the government on this particular issue.
CCSN Presentation John Adams February 1 2024 2.pptx
About this Webinar: John Adams takes a dive behind the headlines, news stories and media releases to better understand any real threats to Canadian patients getting the prescription drugs they need.
CCSN Webinar 2023 2023 11 Diet for PEP.pdf
About this Webinar: We know that methods of eating and diet are a large part of cancer care, but how can you make your diet work for you in your cancer journey? Dr. Rob Rutelege is back to present the latest science around healthy eating and cancer care. In addition, Dr. Rutledge will share the benefits of time-restricted eating, and how you can incorporate it into your daily routine.
CCSN Webinar - EAOCRC FINAL [Autosaved].pptx
Colorectal cancer is the second leading cause of cancer death in Canada, with approximately 24,100 Canadians diagnosed with the disease in 2023. The incidence of colorectal cancer has been declining in Canadians over 50 years of age, largely due to population-based screening programs. Recent evidence has shown, however, that rates have been increasing in adults younger than 50 years. Given that younger adults are typically classified as at low risk for colorectal cancer, this epidemiologic shift is cause for concern.
Individuals under the age of 50 now represent a significant number of colorectal cancer cases. The disease is often being diagnosed at a later stage, and tumour characteristics tend to be more lethal. As for what is accounting for the increasing trend, ongoing research efforts focus on environmental toxicities, lifestyle patterns, and the gut microbiome.
In this webinar, we will present an overview of the current evidence surrounding the rising rates of colorectal cancer in young adults and discuss the unique needs of this patient population, through screening, diagnosis, treatment, and survivorship. A young colorectal cancer patient will share his lived experience in managing this disease and the impact that cancer has had on himself and his family.
CCSN David Ma Nov 9 2023 final.pptx
About this Talk: This talk will provide a nutritional perspective on the role of diet in cancer focusing on healthy fats known as omega-3 fatty acids. Sources, amounts and types of omega-3 fatty acids will be highlighted. Clinical and experimental evidence in support of a role for omega-3 fatty acids in the prevention and treatment of breast cancer will be presented. Lastly, some practical strategies to support a healthy diet will be shared.
CCSN_Husereau_2_Nov.pdf
About the Webinar: Genomic testing has already become commonplace in oncology, but exponential growth in more comprehensive genomic tests, other innovative tests and testing approaches in oncology, as well as a number of other therapeutic areas is expected in the coming years. With the emergence of more complex, more expensive, and more promising tests, policymakers and healthcare providers may be challenged to provide these to patients at the pace of innovation. Don Husereau will describe what conditions are necessary for equitable access to advanced innovative testing, how major Canadian provinces are doing, and what more needs to be done in the coming years to benefit all patients.
CCSN Breast Screening for Women in the 40s(1).pptx
About this Webinar: This talk will explore breast screening for women 40-49. The benefits and harms for screening will be discussed, as well as what is unique about breast cancer in women in their 40s. In order to understand the controversy around current guidelines recommending against screening women 40-49, we will review the evidence upon which these guidelines are based, and their impact on breast cancer outcomes for these women.
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptx
About this Webinar: This presentation will discuss the pathway to pharmaceutical treatments in Canada that involve health technology assessment reviews and decision making. Observations on the current challenges and the importance of patient input to inform decision making will also be discussed. Finally, the key elements that can be critical to successful outcomes will be presented.
AsbestosPresentation-PCNforCCSN-Final-Sept28.pdf
About this Webinar: When Canadians turn on the tap for a drink of water or a shower, we take for granted that the water is safe. Few are aware that old asbestos cement water pipes still deliver water to millions of people. As these pipes age and deteriorate, asbestos erodes into the water and poses health concerns, including cancer.
Dr. Meg Sears, Chair of the Board of Prevent Cancer Now, and board member Julian Branch will talk about the history of asbestos in water, the science behind ingested asbestos, and recent developments.
CCSN EUPROMS.pptx
André Deschamps will show the results of the Europa UOMO Euproms studies. These are the first studies ever from patients for patients, measuring the burden of treatment. More than 5000 patients have shared with us their experiences after treatment. The data has been analyzed by the university of Rotterdam in the Netherlands and has been published in peer reviewed scientific papers.
survivornettalkCancerandWorkP.pdf
This webinar will serve as an introduction to Cancer and Work, a website that “was designed to address the unique needs of cancer survivors with returning, remaining, changing work or looking for work after a diagnosis of cancer. The website provides newly created information, resources, and interactive tools for cancer survivors, healthcare providers, employers, and highlights helpful information from across the globe.” The talk will include 10 steps to return to work, and job search ideas for cancer survivors
Returning-to-Work-after-Cancer-Treatment_BB.pptx
This webinar will have two perspectives.
Jasveen will be presenting about the impact of cancer and treatment on a person’s physical, cognitive & mental health and how an Occupational therapist can work with the person to gradually overcome these challenges to return to work with or without modifications. The presentation will cover some case studies of past success with the opportunity to answer questions at the end.
Then we will hear from Jen who has experienced her own journey with breast cancer and how she advocated for herself and occupational therapy to help her return to full time employment.
CCSN Long Covid FINAL.pptx
About this Webinar: we’ll summarize the findings of a 10-minute online study conducted by Leger among cancer patients who experienced Long-COVID. We identified 119 cancer patients, diagnosed within the past 10 years, who developed symptoms or were diagnosed with Long-COVID. We primarily wanted to understand how Long-COVID impacted cancer patients and their ability to receive treatment. We also asked about the effect on their overall wellbeing, their ability to access Long-COVID treatments and assistance, and the ongoing impact to this day.
About this Presenter: Colette Faust is a Research Director at Leger (largest Canadian-owned market research company) and has 10 years of market research experience, spending the last 3 years in the healthcare industry. As a member of Leger’s North American Healthcare team, Colette has worked on both quantitative and qualitative healthcare research among healthcare professionals, patients, and the general population across a variety of topics including oncology. Colette received her B.A. in Psychology and Media & Communications from Muhlenberg College in Allentown, PA.
CCSN Presentation Getting Your Gut What It Needs A Post Cancer Treatment Guid...
CCSN Presentation Getting Your Gut What It Needs A Post Cancer Treatment Guid...Canadian Cancer Survivor Network
Various cancer treatments can impact one’s gut health and digestive system. This presentation will discuss why a healthy gut is important to overall health. We will talk about the roles the gut is involved in beyond just digestion. We will also discuss nutrition strategies that will support our gut health and promote a healthy microbiome.CCSN Powerpoint Template_planningfornewreality.pptx
In this Webinar, participants will learn about:
– Balancing rising costs and a limited budget
– Eating healthily, food banks, other resources in your community
– Budget formats that work for cancer patients
– Money management
– Debit and credit management
– Credit counselling
– Consumer protection
SayaniAmbreen_SocialInequalitiesANDCancer_April2023.pdf
In this session, we will:
Discuss theories and definitions of social class
Describe the link between social class and health inequities
Use Bartley’s models of health inequities to understand how social class influences cancer risk and mortality using lung cancer as an example.
CS2FS What to expect from Advisors.pptx
In this Webinar, participants will learn:
- How your bank or financial institution can help and what questions to ask
- How your financial advisor can help and the types of services that they may provide
- The potential costs of what to expect
- How your insurance agent can help you with gathering info and services they provide
- RRSP/Investments – what to think about
Update on Cancer Meds Review and Approval 23Mar2023.pptx
About this Webinar: This session will provide participants with an overview of what is involved in getting a new cancer treatment reviewed and approved in Canada. The webinar will feature representatives from 3Sixty Public Affairs, who will detail the key steps required to provide patient access to a new treatment option. The journey begins with a Health Canada review of safety, efficacy and quality. That is followed by comparative cost and effectiveness evaluations and the establishmentof a place in therapy by health technology assessment (HTA) agencies. After the HTA recommendations are issued, then the national pricing negotiation process takes place, followed by reimbursement decision-making at the jurisdictional level. During all that, new products also must pass through a national price review. Patients and stakeholders have some opportunities to provide input at various points in the process. All that and more will be covered during the presentation. Afterward, the presenters will lead an interactive question and answer session that will permit audience members to explore these processes further.
Young Adult Cancer Canada & the 8 Things You Need to Know About Cancer in the...
Young Adult Cancer Canada & the 8 Things You Need to Know About Cancer in the...Canadian Cancer Survivor Network
Cancer is different for young adults. Join Young Adult Cancer Canada’s presentation on our 8 key findings from our YACPrime Study on the intensified impacts of a cancer diagnosis for those in their young adult years, as presented by YACC staff member, social worker, and colorectal cancer survivor, Dani Taylor (she/her).
About this presenter:
Dani is the Manager of Programs and Partnerships at Young Adult Cancer Canada. Dani is an oncology social worker and young adult, colorectal cancer survivor. She has completed her Masters in Social Work with the Factor-Inwentash Faculty of Social Work at University of Toronto, as well as her Bachelor of Social Work and BA in English Literature with York University. Her experiences with the health care system and support of Young Adult Cancer Canada (YACC) led her to explore a career in psychosocial oncology, finding particular interest in illness narratives and systemic violence. Dani has previously worked for Gilda’s Club Greater Toronto (where she continues to facilitate their 20s & 30s Support Group), Sunnybrook Health Sciences Centre (palliative care), and the Princess Margaret Cancer Centre (allogeneic transplant, palliative care, breast cancer survivorship, and phase one clinical trials).Equity_oriented_LCS_CCSN_Nov2022.pdf
Participation in lung cancer screening is lower in populations with the highest burden of lung cancer risk (through the social patterning of smoking behavior) and lowest levels of healthcare utilization (through care which is structurally inaccessible). This leads to a widening of health inequities. In this webinar, participants will learn about inequities across the lung cancer care continuum. They will also learn to understand the need to take an equity-oriented approach to lung cancer screening, and consider future directions for improving access to lung cancer screening in all eligible population groups.
Cancer Survivor to Financial Survivor - Balancing Work and Caregiving from OC...
Cancer Survivor to Financial Survivor - Balancing Work and Caregiving from OC...Canadian Cancer Survivor Network
About this webinar:
Are you or someone you know caring for a family member or friend while trying to balance demands at work? Join us for a session presented by the Ontario Caregiver Organization (OCO). Participants will learn more about caregiving experiences in the workplace, explore the best strategies for balancing work and caregiving, review federal and provincial benefit options, and gain access to free resources focused on their needs.CCSN ODSP disability PLE Nov 16 2022_FINAL(1).pptx
This presentation will focus on the legal test to be considered “disabled” for the purposes of accessing the Ontario Disability Support Program, about the process for getting on ODSP, and about the legal process to challenge a refused ODSP application.
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
More Related Content
More from Canadian Cancer Survivor Network
CCSN Webinar 2023 2023 11 Diet for PEP.pdf
About this Webinar: We know that methods of eating and diet are a large part of cancer care, but how can you make your diet work for you in your cancer journey? Dr. Rob Rutelege is back to present the latest science around healthy eating and cancer care. In addition, Dr. Rutledge will share the benefits of time-restricted eating, and how you can incorporate it into your daily routine.
CCSN Webinar - EAOCRC FINAL [Autosaved].pptx
Colorectal cancer is the second leading cause of cancer death in Canada, with approximately 24,100 Canadians diagnosed with the disease in 2023. The incidence of colorectal cancer has been declining in Canadians over 50 years of age, largely due to population-based screening programs. Recent evidence has shown, however, that rates have been increasing in adults younger than 50 years. Given that younger adults are typically classified as at low risk for colorectal cancer, this epidemiologic shift is cause for concern.
Individuals under the age of 50 now represent a significant number of colorectal cancer cases. The disease is often being diagnosed at a later stage, and tumour characteristics tend to be more lethal. As for what is accounting for the increasing trend, ongoing research efforts focus on environmental toxicities, lifestyle patterns, and the gut microbiome.
In this webinar, we will present an overview of the current evidence surrounding the rising rates of colorectal cancer in young adults and discuss the unique needs of this patient population, through screening, diagnosis, treatment, and survivorship. A young colorectal cancer patient will share his lived experience in managing this disease and the impact that cancer has had on himself and his family.
CCSN David Ma Nov 9 2023 final.pptx
About this Talk: This talk will provide a nutritional perspective on the role of diet in cancer focusing on healthy fats known as omega-3 fatty acids. Sources, amounts and types of omega-3 fatty acids will be highlighted. Clinical and experimental evidence in support of a role for omega-3 fatty acids in the prevention and treatment of breast cancer will be presented. Lastly, some practical strategies to support a healthy diet will be shared.
CCSN_Husereau_2_Nov.pdf
About the Webinar: Genomic testing has already become commonplace in oncology, but exponential growth in more comprehensive genomic tests, other innovative tests and testing approaches in oncology, as well as a number of other therapeutic areas is expected in the coming years. With the emergence of more complex, more expensive, and more promising tests, policymakers and healthcare providers may be challenged to provide these to patients at the pace of innovation. Don Husereau will describe what conditions are necessary for equitable access to advanced innovative testing, how major Canadian provinces are doing, and what more needs to be done in the coming years to benefit all patients.
CCSN Breast Screening for Women in the 40s(1).pptx
About this Webinar: This talk will explore breast screening for women 40-49. The benefits and harms for screening will be discussed, as well as what is unique about breast cancer in women in their 40s. In order to understand the controversy around current guidelines recommending against screening women 40-49, we will review the evidence upon which these guidelines are based, and their impact on breast cancer outcomes for these women.
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptx
About this Webinar: This presentation will discuss the pathway to pharmaceutical treatments in Canada that involve health technology assessment reviews and decision making. Observations on the current challenges and the importance of patient input to inform decision making will also be discussed. Finally, the key elements that can be critical to successful outcomes will be presented.
AsbestosPresentation-PCNforCCSN-Final-Sept28.pdf
About this Webinar: When Canadians turn on the tap for a drink of water or a shower, we take for granted that the water is safe. Few are aware that old asbestos cement water pipes still deliver water to millions of people. As these pipes age and deteriorate, asbestos erodes into the water and poses health concerns, including cancer.
Dr. Meg Sears, Chair of the Board of Prevent Cancer Now, and board member Julian Branch will talk about the history of asbestos in water, the science behind ingested asbestos, and recent developments.
CCSN EUPROMS.pptx
André Deschamps will show the results of the Europa UOMO Euproms studies. These are the first studies ever from patients for patients, measuring the burden of treatment. More than 5000 patients have shared with us their experiences after treatment. The data has been analyzed by the university of Rotterdam in the Netherlands and has been published in peer reviewed scientific papers.
survivornettalkCancerandWorkP.pdf
This webinar will serve as an introduction to Cancer and Work, a website that “was designed to address the unique needs of cancer survivors with returning, remaining, changing work or looking for work after a diagnosis of cancer. The website provides newly created information, resources, and interactive tools for cancer survivors, healthcare providers, employers, and highlights helpful information from across the globe.” The talk will include 10 steps to return to work, and job search ideas for cancer survivors
Returning-to-Work-after-Cancer-Treatment_BB.pptx
This webinar will have two perspectives.
Jasveen will be presenting about the impact of cancer and treatment on a person’s physical, cognitive & mental health and how an Occupational therapist can work with the person to gradually overcome these challenges to return to work with or without modifications. The presentation will cover some case studies of past success with the opportunity to answer questions at the end.
Then we will hear from Jen who has experienced her own journey with breast cancer and how she advocated for herself and occupational therapy to help her return to full time employment.
CCSN Long Covid FINAL.pptx
About this Webinar: we’ll summarize the findings of a 10-minute online study conducted by Leger among cancer patients who experienced Long-COVID. We identified 119 cancer patients, diagnosed within the past 10 years, who developed symptoms or were diagnosed with Long-COVID. We primarily wanted to understand how Long-COVID impacted cancer patients and their ability to receive treatment. We also asked about the effect on their overall wellbeing, their ability to access Long-COVID treatments and assistance, and the ongoing impact to this day.
About this Presenter: Colette Faust is a Research Director at Leger (largest Canadian-owned market research company) and has 10 years of market research experience, spending the last 3 years in the healthcare industry. As a member of Leger’s North American Healthcare team, Colette has worked on both quantitative and qualitative healthcare research among healthcare professionals, patients, and the general population across a variety of topics including oncology. Colette received her B.A. in Psychology and Media & Communications from Muhlenberg College in Allentown, PA.
CCSN Presentation Getting Your Gut What It Needs A Post Cancer Treatment Guid...
CCSN Presentation Getting Your Gut What It Needs A Post Cancer Treatment Guid...Canadian Cancer Survivor Network
Various cancer treatments can impact one’s gut health and digestive system. This presentation will discuss why a healthy gut is important to overall health. We will talk about the roles the gut is involved in beyond just digestion. We will also discuss nutrition strategies that will support our gut health and promote a healthy microbiome.CCSN Powerpoint Template_planningfornewreality.pptx
In this Webinar, participants will learn about:
– Balancing rising costs and a limited budget
– Eating healthily, food banks, other resources in your community
– Budget formats that work for cancer patients
– Money management
– Debit and credit management
– Credit counselling
– Consumer protection
SayaniAmbreen_SocialInequalitiesANDCancer_April2023.pdf
In this session, we will:
Discuss theories and definitions of social class
Describe the link between social class and health inequities
Use Bartley’s models of health inequities to understand how social class influences cancer risk and mortality using lung cancer as an example.
CS2FS What to expect from Advisors.pptx
In this Webinar, participants will learn:
- How your bank or financial institution can help and what questions to ask
- How your financial advisor can help and the types of services that they may provide
- The potential costs of what to expect
- How your insurance agent can help you with gathering info and services they provide
- RRSP/Investments – what to think about
Update on Cancer Meds Review and Approval 23Mar2023.pptx
About this Webinar: This session will provide participants with an overview of what is involved in getting a new cancer treatment reviewed and approved in Canada. The webinar will feature representatives from 3Sixty Public Affairs, who will detail the key steps required to provide patient access to a new treatment option. The journey begins with a Health Canada review of safety, efficacy and quality. That is followed by comparative cost and effectiveness evaluations and the establishmentof a place in therapy by health technology assessment (HTA) agencies. After the HTA recommendations are issued, then the national pricing negotiation process takes place, followed by reimbursement decision-making at the jurisdictional level. During all that, new products also must pass through a national price review. Patients and stakeholders have some opportunities to provide input at various points in the process. All that and more will be covered during the presentation. Afterward, the presenters will lead an interactive question and answer session that will permit audience members to explore these processes further.
Young Adult Cancer Canada & the 8 Things You Need to Know About Cancer in the...
Young Adult Cancer Canada & the 8 Things You Need to Know About Cancer in the...Canadian Cancer Survivor Network
Cancer is different for young adults. Join Young Adult Cancer Canada’s presentation on our 8 key findings from our YACPrime Study on the intensified impacts of a cancer diagnosis for those in their young adult years, as presented by YACC staff member, social worker, and colorectal cancer survivor, Dani Taylor (she/her).
About this presenter:
Dani is the Manager of Programs and Partnerships at Young Adult Cancer Canada. Dani is an oncology social worker and young adult, colorectal cancer survivor. She has completed her Masters in Social Work with the Factor-Inwentash Faculty of Social Work at University of Toronto, as well as her Bachelor of Social Work and BA in English Literature with York University. Her experiences with the health care system and support of Young Adult Cancer Canada (YACC) led her to explore a career in psychosocial oncology, finding particular interest in illness narratives and systemic violence. Dani has previously worked for Gilda’s Club Greater Toronto (where she continues to facilitate their 20s & 30s Support Group), Sunnybrook Health Sciences Centre (palliative care), and the Princess Margaret Cancer Centre (allogeneic transplant, palliative care, breast cancer survivorship, and phase one clinical trials).Equity_oriented_LCS_CCSN_Nov2022.pdf
Participation in lung cancer screening is lower in populations with the highest burden of lung cancer risk (through the social patterning of smoking behavior) and lowest levels of healthcare utilization (through care which is structurally inaccessible). This leads to a widening of health inequities. In this webinar, participants will learn about inequities across the lung cancer care continuum. They will also learn to understand the need to take an equity-oriented approach to lung cancer screening, and consider future directions for improving access to lung cancer screening in all eligible population groups.
Cancer Survivor to Financial Survivor - Balancing Work and Caregiving from OC...
Cancer Survivor to Financial Survivor - Balancing Work and Caregiving from OC...Canadian Cancer Survivor Network
About this webinar:
Are you or someone you know caring for a family member or friend while trying to balance demands at work? Join us for a session presented by the Ontario Caregiver Organization (OCO). Participants will learn more about caregiving experiences in the workplace, explore the best strategies for balancing work and caregiving, review federal and provincial benefit options, and gain access to free resources focused on their needs.CCSN ODSP disability PLE Nov 16 2022_FINAL(1).pptx
This presentation will focus on the legal test to be considered “disabled” for the purposes of accessing the Ontario Disability Support Program, about the process for getting on ODSP, and about the legal process to challenge a refused ODSP application.
More from Canadian Cancer Survivor Network (20)
CCSN Breast Screening for Women in the 40s(1).pptx
CCSN Breast Screening for Women in the 40s(1).pptx
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptx
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptx
CCSN Presentation Getting Your Gut What It Needs A Post Cancer Treatment Guid...
CCSN Presentation Getting Your Gut What It Needs A Post Cancer Treatment Guid...
CCSN Powerpoint Template_planningfornewreality.pptx
CCSN Powerpoint Template_planningfornewreality.pptx
SayaniAmbreen_SocialInequalitiesANDCancer_April2023.pdf
SayaniAmbreen_SocialInequalitiesANDCancer_April2023.pdf
Update on Cancer Meds Review and Approval 23Mar2023.pptx
Update on Cancer Meds Review and Approval 23Mar2023.pptx
Young Adult Cancer Canada & the 8 Things You Need to Know About Cancer in the...
Young Adult Cancer Canada & the 8 Things You Need to Know About Cancer in the...
Cancer Survivor to Financial Survivor - Balancing Work and Caregiving from OC...
Cancer Survivor to Financial Survivor - Balancing Work and Caregiving from OC...
CCSN ODSP disability PLE Nov 16 2022_FINAL(1).pptx
CCSN ODSP disability PLE Nov 16 2022_FINAL(1).pptx
Recently uploaded
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By Our Agency
ICH Guidelines for Pharmacovigilance.pdf
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Health Education on prevention of hypertension
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Dimensions of Healthcare Quality
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
How many patients does case series should have In comparison to case reports.pdf
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Myopia Management & Control Strategies.pptx
Myopia is becoming epidemic burden globally. Different strategies are mentioned in this presentation to combat Myopia.
CONSTRUCTION OF TEST IN MANAGEMENT .docx
Construction of tests assignment
Subject: Leadership and management.
Nurse Practitioner in Critical Care 1st year
ABDOMINAL COMPARTMENT SYSNDROME
CARE OF CLIENTS WITH LIFE-THREATENING CONDITIONS, ACUTELY ILL/ MULTI-ORGAN PROBLEMS, HIGH ACUITY AND EMERGENCY SITUATION
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Haridwar ESCORTS💦
The Importance of Community Nursing Care.pdf
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health with Aboud Health Group. Explore comprehensive care options for women's wellness needs in Mississauga.
Recently uploaded (20)
The Impact of Meeting: How It Can Change Your Life
The Impact of Meeting: How It Can Change Your Life
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
Mindful Eating CCSN Final.pptx
- 31. Canadian Cancer Survivor Network Contact Info 1750 Courtwood Crescent, Suite 210 Ottawa, ON K2C 2B5 Telephone / Téléphone : 613-898-1871 E-mail: jmanthorne@survivornet.ca or info@survivornet.ca Website: www.survivornet.ca Twitter: @survivornetca Facebook: www.facebook.com/CanadianSurvivorNet Instagram: @survivornet_ca Pinterest: http://pinterest.com/survivornetwork/